Cargando…

Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes

Gestational diabetes mellitus (GDM) increases the risk of early-onset type 2 diabetes, which further exacerbates the risk of developing diabetic complications such as kidney, circulatory, and neurological complications. Yet, existing models have solely focused on the prediction of type 2 diabetes, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukah, Ugochinyere Vivian, Platt, Robert W., Auger, Nathalie, Dasgupta, Kaberi, Dayan, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209541/
https://www.ncbi.nlm.nih.gov/pubmed/35726008
http://dx.doi.org/10.1038/s41598-022-14215-9
_version_ 1784729978144817152
author Ukah, Ugochinyere Vivian
Platt, Robert W.
Auger, Nathalie
Dasgupta, Kaberi
Dayan, Natalie
author_facet Ukah, Ugochinyere Vivian
Platt, Robert W.
Auger, Nathalie
Dasgupta, Kaberi
Dayan, Natalie
author_sort Ukah, Ugochinyere Vivian
collection PubMed
description Gestational diabetes mellitus (GDM) increases the risk of early-onset type 2 diabetes, which further exacerbates the risk of developing diabetic complications such as kidney, circulatory, and neurological complications. Yet, existing models have solely focused on the prediction of type 2 diabetes, and not of its complications, which are arguably the most clinically relevant outcomes. Our aim was to develop a prediction model for type 2 diabetic complications in patients with GDM. Using provincial administrative data from Quebec, Canada, we developed a model to predict type 2 diabetic complications within 10 years among 90,143 women with GDM. The model was internally validated and assessed for discrimination, calibration, and risk stratification accuracy. The incidence of diabetic complications was 3.8 (95% confidence interval (CI) 3.4–4.3) per 10,000 person-years. The final prediction model included maternal age, socioeconomic deprivation, substance use disorder, gestational age at delivery, severe maternal morbidity, previous pregnancy complications, and hypertensive disorders of pregnancy. The model had good discrimination [area under the curve (AUROC) 0.72 (95% CI 0.69–0.74)] and calibration (slope ≥ 0.9) to predict diabetic complications. In the highest category of the risk stratification table, the positive likelihood ratio was 8.68 (95% CI 4.14–18.23), thereby showing a moderate ability to identify women at highest risk of developing type 2 diabetic complications. Our model predicts the risk of type 2 diabetic complications with moderate accuracy and, once externally validated, may prove to be a useful tool in the management of women after GDM.
format Online
Article
Text
id pubmed-9209541
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92095412022-06-22 Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes Ukah, Ugochinyere Vivian Platt, Robert W. Auger, Nathalie Dasgupta, Kaberi Dayan, Natalie Sci Rep Article Gestational diabetes mellitus (GDM) increases the risk of early-onset type 2 diabetes, which further exacerbates the risk of developing diabetic complications such as kidney, circulatory, and neurological complications. Yet, existing models have solely focused on the prediction of type 2 diabetes, and not of its complications, which are arguably the most clinically relevant outcomes. Our aim was to develop a prediction model for type 2 diabetic complications in patients with GDM. Using provincial administrative data from Quebec, Canada, we developed a model to predict type 2 diabetic complications within 10 years among 90,143 women with GDM. The model was internally validated and assessed for discrimination, calibration, and risk stratification accuracy. The incidence of diabetic complications was 3.8 (95% confidence interval (CI) 3.4–4.3) per 10,000 person-years. The final prediction model included maternal age, socioeconomic deprivation, substance use disorder, gestational age at delivery, severe maternal morbidity, previous pregnancy complications, and hypertensive disorders of pregnancy. The model had good discrimination [area under the curve (AUROC) 0.72 (95% CI 0.69–0.74)] and calibration (slope ≥ 0.9) to predict diabetic complications. In the highest category of the risk stratification table, the positive likelihood ratio was 8.68 (95% CI 4.14–18.23), thereby showing a moderate ability to identify women at highest risk of developing type 2 diabetic complications. Our model predicts the risk of type 2 diabetic complications with moderate accuracy and, once externally validated, may prove to be a useful tool in the management of women after GDM. Nature Publishing Group UK 2022-06-20 /pmc/articles/PMC9209541/ /pubmed/35726008 http://dx.doi.org/10.1038/s41598-022-14215-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ukah, Ugochinyere Vivian
Platt, Robert W.
Auger, Nathalie
Dasgupta, Kaberi
Dayan, Natalie
Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
title Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
title_full Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
title_fullStr Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
title_full_unstemmed Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
title_short Development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
title_sort development and internal validation of a model to predict type 2 diabetic complications after gestational diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209541/
https://www.ncbi.nlm.nih.gov/pubmed/35726008
http://dx.doi.org/10.1038/s41598-022-14215-9
work_keys_str_mv AT ukahugochinyerevivian developmentandinternalvalidationofamodeltopredicttype2diabeticcomplicationsaftergestationaldiabetes
AT plattrobertw developmentandinternalvalidationofamodeltopredicttype2diabeticcomplicationsaftergestationaldiabetes
AT augernathalie developmentandinternalvalidationofamodeltopredicttype2diabeticcomplicationsaftergestationaldiabetes
AT dasguptakaberi developmentandinternalvalidationofamodeltopredicttype2diabeticcomplicationsaftergestationaldiabetes
AT dayannatalie developmentandinternalvalidationofamodeltopredicttype2diabeticcomplicationsaftergestationaldiabetes